Topic: Glp 1

Lawsuits are emerging against the makers of Ozempic and other GLP-1 drugs, alleging they can cause "NAION," a condition that leads to sudden and permanent blindness. One patient, Todd Engel, lost vision in both eyes after taking the drug for diabetes, a side effect he claims was not properly disclosed. Medical research has recently indicated a higher rate of optic neuropathy among diabetic patients using these weight-loss medications.

Andrew Horowitz and Adam Curry discuss the side effects of GLP-1 weight loss drugs, specifically the loss of muscle mass in older patients. Horowitz shares an "off-stage" comment from a chief medical officer regarding an increase in falls and injuries among users. Horowitz maintains that he has avoided muscle loss by working out three days a week while using the medication.

McDonald's is investing $8.5 billion to combat sagging sales by redesigning restaurants and improving food quality. Reuters reports that the chain is using an AI "pricing engine" to set "optimal" prices based on customer willingness to pay, leading to significant price variations between nearby locations. Additionally, McDonald's is exploring smaller, high-protein menu options to cater to customers using GLP-1 weight loss drugs.